University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis

Simple item page
dc.contributor.authorPons, Marion
dc.contributor.authorGeorgiadis, Stylianos
dc.contributor.authorØstergaard, Mikkel
dc.contributor.authorAhmadzay, Zohra Faizy
dc.contributor.authorGlintborg, Bente
dc.contributor.authorHeberg, Jette
dc.contributor.authorChristensen, Sara Nysom
dc.contributor.authorRasmussen, Simon H.
dc.contributor.authorLoft, Anne Gitte
dc.contributor.authorCastrejon, Isabel
dc.contributor.authorSánchez-Alonso, Fernando
dc.contributor.authorIannone, Florenzo
dc.contributor.authorNordström, Dan
dc.contributor.authorHokkanen, Anna-Mari
dc.contributor.authorCiurea, Adrian
dc.contributor.authorNissen, Michael J
dc.contributor.authorZavada, Jakub
dc.contributor.authorPavelka, Karel
dc.contributor.authorRotar, Ziga
dc.contributor.authorPirkmajer, Katja Perdan
dc.contributor.authorMichelsen, Brigitte
dc.contributor.authorMielnik, Pawel
dc.contributor.authorBernardes, Miguel
dc.contributor.authorKhmelinskii, Nikita
dc.contributor.authorLaas, Karin
dc.contributor.authorVorobjov, Sigrid
dc.contributor.authorCodreanu, Catalin
dc.contributor.authorMacfarlane, Gary J.
dc.contributor.authorJones, Gareth
dc.contributor.authorGudbjornsson, Bjorn
dc.contributor.authorPalsson, Olafur
dc.contributor.authorWallman, Johan K
dc.contributor.authorvan der Horst-Bruinsma, Irene E
dc.contributor.authorOnen, Fatos
dc.contributor.authorHetland, Merete Lund
dc.contributor.authorØrnbjerg, Lykke Midtbøll
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2025-01-27T12:01:01Z
dc.date.available2025-01-27T12:01:01Z
dc.date.issued2025-05
dc.descriptionOn behalf of the EuroSpA Scientific Committee, the authors acknowledge Novartis Pharma AG for supporting the EuroSpA collaboration. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit for publication.en
dc.description.statusPeer revieweden
dc.format.extent13
dc.format.extent988595
dc.identifier298686647
dc.identifier0ba2248a-c6fe-4374-ab12-d39899c16ba7
dc.identifier85215619493
dc.identifier.citationPons, M, Georgiadis, S, Østergaard, M, Ahmadzay, Z F, Glintborg, B, Heberg, J, Christensen, S N, Rasmussen, S H, Loft, A G, Castrejon, I, Sánchez-Alonso, F, Iannone, F, Nordström, D, Hokkanen, A-M, Ciurea, A, Nissen, M J, Zavada, J, Pavelka, K, Rotar, Z, Pirkmajer, K P, Michelsen, B, Mielnik, P, Bernardes, M, Khmelinskii, N, Laas, K, Vorobjov, S, Codreanu, C, Macfarlane, G J, Jones, G, Gudbjornsson, B, Palsson, O, Wallman, J K, van der Horst-Bruinsma, I E, Onen, F, Hetland, M L & Ørnbjerg, L M 2025, 'Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis', Joint, Bone,Spine, vol. 92, no. 3, 105824. https://doi.org/10.1016/j.jbspin.2024.105824en
dc.identifier.doi10.1016/j.jbspin.2024.105824
dc.identifier.iss3en
dc.identifier.issn1297-319X
dc.identifier.otherORCID: /0000-0003-0016-7591/work/173415952
dc.identifier.urihttps://hdl.handle.net/2164/24944
dc.identifier.vol92en
dc.language.isoeng
dc.relation.ispartofJoint, Bone,Spineen
dc.subjectspondyloarthritisen
dc.subjectepidemiologyen
dc.subjectbDMARDen
dc.subjectR Medicine (General)en
dc.subject.lccR1en
dc.titleFour-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritisen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Pons_etal_JBS_Four_year_secukinumab_VOR.pdf
Size:
965.42 KB
Format:
Adobe Portable Document Format
Download

Collections

All research